Bellevue Group AG Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001674546

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q3 2025 · 148 positions · Total reported value $4.81B · Top-10 concentration 49.9% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 61.0% · 17 new · 64 cut · 24 exited

Active Share (vs S&P 500): 94.1% · vs QQQ: 96.5% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +12.4% · vs SPY -2.4% · Prev Value $4.20B — last quarter positions weighted by this quarter price moves · ranking

In its Q3 2025 13F filing, Bellevue Group AG disclosed 148 equity positions with a combined reported value of $4.81B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 49.9% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2025 were IONS ($408.51M), ARGX ($402.95M), RVMD ($260.30M). By sector, the heaviest allocations are Health Care 91.8%, Industrials 1.9%. Versus the prior quarter, allocation shifted toward Other (+1.0pp) and away from Health Care (-1.0pp).

Versus the prior quarter, Bellevue Group AG opened 17 new positions, trimmed 64 and fully exited 24, a turnover rate of 61.0% of positions. The portfolio's overlap with the prior quarter was 82% of names.

The largest new positions opened in Q3 2025 were RNAM ($93.80M), THC ($8.20M), ICLR ($4.24M).

Of the 24 positions fully exited versus the prior quarter, the largest were BPMC ($36.52M), BDTX ($6.78M), VRNA ($1.51M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2025)

  • RNAM AVIDITY BIOSCIENCES INC · $93.80M
  • THC TENET HEALTHCARE CORP · $8.20M
  • ICLR ICON PUB LTD CO · $4.24M
  • ADPT ADAPTIVE BIOTECHNOLOGIES COR · $2.52M
  • VKTX VIKING THERAPEUTICS INC · $2.00M
  • AVTR AVANTOR INC · $1.29M
  • UTHR UNITED THERAPEUTICS CORP DEL · $1.11M
  • BKD BROOKDALE SR LIVING INC · $886.51K

Fully Exited (vs previous quarter)

  • BPMC BLUEPRINT MEDICINES CORP · prev qtr: $36.52M
  • BDTX BLACK DIAMOND THERAPEUTICS I · prev qtr: $6.78M
  • VRNA VERONA PHARMA PLC · prev qtr: $1.51M
  • NVO NOVO-NORDISK A S · prev qtr: $448.63K
  • ARQT ARCUTIS BIOTHERAPEUTICS INC · prev qtr: $336.59K
  • ADMA ADMA BIOLOGICS INC · prev qtr: $307.75K
  • TVTX TRAVERE THERAPEUTICS INC · prev qtr: $270.88K
  • MTSR METSERA INC · prev qtr: $221.91K

Insider Transactions (Form 4)

Latest Bellevue Group AG buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Bellevue Group AG files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 148 positions worth $4.75B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Portfolio Structure

  • 148 positions · $4.75B reported value (Q2 2026)
  • Top 10 holdings = 42.9% of reported value
  • Largest position: AMGN (AMGEN INC) at 6.5%
  • Average position size: $32.11M

Sector Tilt

  • Health Care 92.6%
  • Industrials 1.7%
  • Information Technology 0.4%
  • (classified holdings cover 95% of value)

Quarterly Activity

  • Q2 2026: 17 new, 39 added, 64 reduced, 24 exited
  • 28 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 91.8%
Technology 0.8%
Other 5.3%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 6.24M $408.51M 8.49%
8.49%
Reduce
2 546.33K $402.95M 8.37%
8.37%
Reduce
3 5.57M $260.30M 5.41%
5.41%
Add
4 1.76M $247.50M 5.14%
5.14%
Reduce
5 446.52K $203.61M 4.23%
4.23%
Reduce
6 505.81K $198.09M 4.12%
4.12%
Add
7 1.48M $198.04M 4.12%
4.12%
Reduce
8 451.10K $166.76M 3.46%
3.46%
Reduce
9 1.66M $162.05M 3.37%
3.37%
Reduce
10 348.63K $155.92M 3.24%
3.24%
Reduce
11 3.71M $149.11M 3.10%
3.10%
Add
12 1.44M $122.18M 2.54%
2.54%
Reduce
13 3.24M $120.83M 2.51%
2.51%
Add
14 2.39M $113.44M 2.36%
2.36%
Add
15 2.80M $101.61M 2.11%
2.11%
Add
16 2.15M $93.80M 1.95%
1.95%
New
17 3.56M $92.04M 1.91%
1.91%
Add
18 759.86K $72.37M 1.50%
1.50%
Reduce
19 2.89M $70.12M 1.46%
1.46%
Hold
20 896.63K $69.73M 1.45%
1.45%
Add
21 212.00K $65.45M 1.36%
1.36%
Reduce
22 170.06K $58.72M 1.22%
1.22%
Add
23 296.89K $55.57M 1.16%
1.16%
Reduce
24 786.12K $52.90M 1.10%
1.10%
Reduce
25 106.19K $51.50M 1.07%
1.07%
Reduce
26 76.59K $48.93M 1.02%
1.02%
Hold
27 164.83K $45.12M 0.94%
0.94%
Reduce
28 2.78M $45.03M 0.94%
0.94%
Hold
29 8.35M $43.56M 0.91%
0.91%
Add
30 2.80M $42.07M 0.87%
0.87%
Hold
31 170.87K $39.56M 0.82%
0.82%
Add
32 146.90K $37.21M 0.77%
0.77%
Reduce
33 122.49K $35.31M 0.73%
0.73%
Add
34 463.06K $34.78M 0.72%
0.72%
Reduce
35 104.97K $33.92M 0.70%
0.70%
Add
36 163.88K $32.49M 0.68%
0.68%
Add
37 40.51K $30.91M 0.64%
0.64%
Reduce
38 4.09M $29.97M 0.62%
0.62%
Hold
39 37.96K $29.32M 0.61%
0.61%
Reduce
40 118.11K $29.23M 0.61%
0.61%
Add
41 97.51K $29.05M 0.60%
0.60%
Reduce
42 65.61K $27.96M 0.58%
0.58%
Reduce
43 245.20K $24.15M 0.50%
0.50%
Reduce
44 292.26K $20.04M 0.42%
0.42%
Reduce
45 76.31K $19.85M 0.41%
0.41%
Add
46 326.87K $18.72M 0.39%
0.39%
Reduce
47 144.68K $18.12M 0.38%
0.38%
Reduce
48 90.98K $17.41M 0.36%
0.36%
Add
49 247.89K $16.73M 0.35%
0.35%
Hold
50 9.92M $16.67M 0.35%
0.35%
Hold

FAQ

What did Bellevue Group AG buy in 2025-Q3?

In its 2025-Q3 13F filing, Bellevue Group AG reported 148 equity positions worth $4.81B in aggregate; its largest disclosed positions were IONS ($408.51M), ARGX ($402.95M), RVMD ($260.30M).

How large is Bellevue Group AG's portfolio?

Bellevue Group AG reported $4.81B of long equity holdings across 148 positions as of 2025-Q3. Top-10 holdings account for 49.9% of reported value.

What is Bellevue Group AG's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/bellevue-group-ag/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →